- Weekly jobless claims fall, Q1 GDP unrevised at 6.4%
- Tesla shares boost Nasdaq, S&P 500
- Lilly jumps on plan to seek approval for Alzheimer's drug
- Indexes: Dow +0.95%, S&P 500 +0.58%, Nasdaq +0.69%
June 24 (Reuters) - The Nasdaq and the S&P 500 indexes closed at record highs on Thursday, with the Dow also jumping almost 1% after U.S. President Joe Biden embraced a bipartisan Senate infrastructure deal.
With massive fiscal stimulus helped the U.S. economy grow at a 6.4% annualized rate in the first quarter, investors have been banking on an infrastructure agreement that could steer the next leg of the recovery for the world's largest economy and fuel more stock gains. read more
"In the short term, I think there will be some 'buy the rumor and sell the news' in materials and industrials, but as we start to see more details come out about how the money will be spent, I think we will get a continued benefit," said Sal Bruno, chief investment officer at IndexIQ in New York.
Fueling the S&P 500's gains more than any other stock, Tesla Inc (TSLA.O) rose 3.5% after Chief Executive Officer Elon Musk said he would list SpaceX's space internet venture, Starlink, when its cash flow is reasonably predictable, adding that Tesla shareholders could get preference in investing. read more
Microsoft (MSFT.O) added 0.5% and ended with a market capitalization above $2 trillion for its first time.
Initial claims for state unemployment benefits fell 7,000 to 411,000 for the week ended June 19, the Labor Department said on Thursday, but were still higher than the 380,000 that economists had forecast. read more
The Commerce Department said the economy grew at a 6.4% rate last quarter, unrevised from the estimate published in May.
The Nasdaq Composite (.IXIC) climbed 0.69% to 14,369.71.
Volume on U.S. exchanges was 9.2 billion shares, less than the 11.0 billion average over the last 20 trading days.
So far in 2021, the S&P 500 has gained almost 14%, beating the Nasdaq's 11% rise.
Eli Lilly and Co (LLY.N)jumped 7.3% to a record high after the drugmaker said it would apply for the U.S. Food and Drug Administration's accelerated approval for its experimental Alzheimer's drug this year. read more
In response, Biogen Inc (BIIB.O), which received a controversial approval for its Alzheimer's drug aducanumab earlier this month, tumbled 6.1%.
MGM Resorts International (MGM.N) rose 2.2% after Deutsche Bank upgraded the casino operator's stock to "buy" from "hold."
Advancing issues outnumbered declining ones on the NYSE by a 2.29-to-1 ratio; on Nasdaq, a 2.44-to-1 ratio favored advancers.
The S&P 500 posted 36 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 105 new highs and 27 new lows.
Our Standards: The Thomson Reuters Trust Principles.